APA (7th ed.) Citation

D, S., V, P., J, T., C, M., O, Z., & P, B. L. (2024). Case Report: Single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy. Frontiers in oral health, 5, 1473049. https://doi.org/10.3389/froh.2024.1473049

Chicago Style (17th ed.) Citation

D, Száraz, Peřina V, Treglerová J, Macháček C, Zendulka O, and Bořilová Linhartová P. "Case Report: Single Low-dose of Denosumab as a Trigger of MRONJ Development in a Patient with Osteoporosis After Bisphosphonate Therapy." Frontiers in Oral Health 5 (2024): 1473049. https://doi.org/10.3389/froh.2024.1473049.

MLA (9th ed.) Citation

D, Száraz, et al. "Case Report: Single Low-dose of Denosumab as a Trigger of MRONJ Development in a Patient with Osteoporosis After Bisphosphonate Therapy." Frontiers in Oral Health, vol. 5, 2024, p. 1473049, https://doi.org/10.3389/froh.2024.1473049.